SUPERNUS PHARMACEUTICALS, INC.
Ticker: 1356576
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 207.71+8.1% | 192.10+16.1% | 165.45+10.4% | 149.82-14.7% | 175.69+4.4% | 168.33+17.2% | 143.64-6.7% | 153.88 |
| Total Income | 207.71+8.1% | 192.10+16.1% | 165.45+10.4% | 149.82-14.7% | 175.69+4.4% | 168.33+17.2% | 143.64-6.7% | 153.88 |
| EXPENSES | ||||||||
| Expenditure | 216.04-14.4% | 252.33+64.6% | 153.31-4.2% | 160.08+18.7% | 134.84-7.5% | 145.76-0.7% | 146.80+0.7% | 145.74 |
| Tax | -3.66+71.5% | -12.84-120.2% | -5.83-197.2% | 6.00-7.0% | 6.45+0.9% | 6.39+5225.0% | 0.12-99.5% | 25.87 |
| PROFIT | ||||||||
| PBT | -5.95+89.7% | -57.95-447.6% | 16.67+385.9% | -5.83-113.0% | 44.94+70.9% | 26.30+10858.3% | 0.24-97.6% | 9.89 |
| Net Profit | -2.29+94.9% | -45.12-300.5% | 22.50+290.2% | -11.83-130.7% | 38.50+93.3% | 19.92+16500.0% | 0.12+100.8% | -15.98 |
| KEY METRICS | ||||||||
| OPM % | -4.01%+27.34pp | -31.35%-38.69pp | 7.34%+14.18pp | -6.84%-30.09pp | 23.25%+9.84pp | 13.41%+15.60pp | -2.19%-7.48pp | 5.29% |
| NPM % | -1.10%+22.38pp | -23.49%-37.08pp | 13.60%+21.49pp | -7.89%-29.81pp | 21.91%+10.08pp | 11.83%+11.75pp | 0.09%+10.47pp | -10.38% |
| EPS | -0.04+95.0% | -0.80-300.0% | 0.40+290.5% | -0.21-130.0% | 0.70+94.4% | 0.36 | 0.00+100.0% | -0.29 |
Corporate Events
Board MeetingSUPN
202618Jun
Board Meeting
Annual Meeting of Stockholders voting results, including the…
SEC Filing ↗